Light Line Medical, Inc.

Light Line Medical, Inc.’s patented visible-light platform technology is an infection prevention game-changer, destined to create a massive global shift in how the world prevents and treats healthcare-associated infections. The CDC reported that each year over 2 million people in the United States are infected by antibiotic-resistant bacteria and over 23,000 people die from these infections [1]. Without relying on drugs, chemicals, or UV light, visible light technology is the first antimicrobial for all infections, including antibiotic-resistant bacteria, which the CDC has identified as “one of the world’s most pressing public health threats” [2]. Light Line Medical has developed a proprietary method of delivering light to prevent and treat catheter-associated infections. This technology uses non-UV visible light to kill bacteria and prevent biofilm both intra and extraluminally.